CoChat

Acute administration of the cannabinoid CB1 antagonist rimonabant impairs positive affective memory in healthy volunteers

Horder, Jamie, Cowen, Philip J., Di Simplicio, Martina, Browning, Michael, Harmer, Catherine J. · 2009 · Psychopharmacology

The DOI matches its Crossref record; 19 of the 20 references it cites were found in a registry or an index.

Abstract

Background Emotional processing measures are sensitive to acute administration of clinically useful antidepressant drugs. We wished to test the hypothesis that these models would also be able to detect agents likely to cause depression as an adverse effect. The anti-obesity drug and cannabinoid type 1 receptor antagonist, rimonabant, is associated with significant rates of depression and anxiety in clinical use.Materials and methods Thirty healthy adult volunteers were randomly assigned to receive a single dose of rimonabant (20 mg) or lactose placebo in a double-blind, between-groups design. Three hours after medication administration, subjects undertook an emotional processing test battery including facial emotion recognition, emotional word attentional dot probe, self-relevant word classification, emotional and declarative memory and the emotion-potentiated acoustic startle response. Subjective state was assessed via self-report measures.Results A single dose of rimonabant did not alter subjective mood. However, rimonabant selectively reduced incidental recall of positive self-relevant adjectives, an effect contrary to that seen following the administration of antidepressants. There were no effects of rimonabant on the other measures of emotional processing.Conclusions These results suggest that a single dose of rimonabant decreases positive emotional memory in the absence of changes in subjective state. Further studies are required to examine whether rimonabant might produce a wider range of negative emotional biases with repeated treatment.

Overview

Integrity signals

Registry

Crossref · 10.1007/s00213-009-1517-4

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 19 references

Cited by

See all 69

Metadata

Authors
Horder, J., Cowen, P. J., Di Simplicio, M., Browning, M., & Harmer, C. J.
Affiliations
Warneford Hospital (GB)
Corresponding author
Harmer, Catherine J.
Venue
Psychopharmacology
Published
2009-04-01
Volume
205
Issue
1
Pages
85-91
ISSN
  • 0033-3158 (ISSN-L)
  • 1432-2072
OpenAlex
W2013819113
Cited by
69
References
20
Citations by year
2026: 2 · 2025: 2 · 2024: 2 · 2023: 1 · 2022: 1 · 2021: 4 · 2020: 4 · 2019: 2 · 2018: 3 · 2017: 7 · 2016: 2 · 2015: 12 · 2014: 3 · 2013: 7 · 2012: 5
FWCI
3.83
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Psychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
Funders
Medical Research Council
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Keywords
rimonabant, cannabinoid CB1 receptor antagonist, emotional memory, depression, antidepressant side effects, incidental recall, facial emotion recognition, subjective mood, anti-obesity drugs
MeSH terms
Rimonabant, Acoustic Stimulation, Adolescent, Adult, Analysis of Variance, Dose-Response Relationship, Drug, Double-Blind Method, Emotions, Female, Humans, Male, Memory, Memory Disorders, Neuropsychological Tests, Pain Measurement, Pattern Recognition, Visual, Personality Inventory, Piperidines, Pyrazoles, Reflex, Startle, Time Factors, Verbal Learning, Recognition, Psychology, Receptor, Cannabinoid, CB1, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Acute administration of the cannabinoid CB1 antagonist rimonabant impairs positive affective memory in healthy volunteers. https://app.cochat.ai/papers/10.1007/s00213-009-1517-4
The paper
Horder, J., Cowen, P. J., Di Simplicio, M., Browning, M., & Harmer, C. J. (2009). Acute administration of the cannabinoid CB1 antagonist rimonabant impairs positive affective memory in healthy volunteers. Psychopharmacology. https://doi.org/10.1007/s00213-009-1517-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.